Genotech Health And Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.05 Cr
- Revenue Growth 5.41%
- Profit Growth 25.35%
- Ebitda 14.29%
- Net Worth -98.08%
- Total Assets 34.94%
About Genotech Health And Life Sciences
Genotech Health And Life Sciences Private Limited (GHALSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 June 2016 (Eight years and seven months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹12.05 Cr.
Ravi Pericherla, Lakamsani Hymavathi, and Suryanarayana Kolagani serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24304TG2016PTC110484
-
Company No.
110484
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jun 2016
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Genotech Health And Life Sciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravi Pericherla
|
Director | 23-Jun-2016 | Current |
|
Lakamsani Hymavathi
|
Director | Current | |
|
Suryanarayana Kolagani
|
Director | 23-Jun-2016 | Current |
Financial Performance of Genotech Health And Life Sciences.
Genotech Health And Life Sciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.41% increase. The company also saw a substantial improvement in profitability, with a 25.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 98.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genotech Health And Life Sciences?
In 2023, Genotech Health And Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Genotech Pharmaceuticals Private LimitedRavi Pericherla and Suryanarayana Kolagani are mutual person
-
Genex Laboratories Private LimitedRavi Pericherla is a mutual person
-
Medha Pharma Private LimitedLakamsani Hymavathi is a mutual person
Charges (Loans)
₹12.05 Cr
₹0
Charges Breakdown by Lending Institutions
- Karnataka Bank Ltd. : 12.00 Cr
- Hdfc Bank Limited : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2024 | Karnataka Bank Ltd. | ₹12.00 Cr | Open |
| 12 Sep 2023 | Hdfc Bank Limited | ₹0.50 M | Open |
How Many Employees Work at Genotech Health And Life Sciences?
Unlock and access historical data on people associated with Genotech Health And Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genotech Health And Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genotech Health And Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
